# Effect of Intravitreal Bevacizumab on Early Post-Vitrectomy Hemorrhage in Diabetic Patients

> **NCT00524875** · NA · UNKNOWN · sponsor: **Shahid Beheshti University of Medical Sciences** · enrollment: 80 (estimated)

## Conditions studied

- Diabetic Retinopathy

## Interventions

- **DRUG:** Bevacizumab

## Key facts

- **NCT ID:** NCT00524875
- **Lead sponsor:** Shahid Beheshti University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-01
- **Primary completion:** —
- **Final completion:** 2007-09
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2007-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00524875

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00524875, "Effect of Intravitreal Bevacizumab on Early Post-Vitrectomy Hemorrhage in Diabetic Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00524875. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*